This study demonstrates antimicrobial effectiveness and improved properties in hemicellulose films, indicating high-pressure homogenization benefits.
Antimicrobial food packaging with natural antimicrobials and biodegradable polymers presents an innovative solution to mitigate microbial contamination, prolong freshness, reduce food waste, and alleviate environmental burden. This study developed antimicrobial hemicellulose-based films by incorporating carvacrol (1% and 2%) as a natural antimicrobial agent through micro-emulsification produced by high-pressure homogenization (M-films). For comparison, films with the same formula were constructed using coarse emulsions (C-films) without high-pressure homogenization. These films were investigated for their antimicrobial efficacy, mechanical and barrier properties, and physicochemical attributes to explore their potential as sustainable antimicrobial packaging solutions. The M-films demonstrated superior antimicrobial activity, achieving reductions exceeding 4 Log CFU/mL against Listeria monocytogenes, Escherichia coli, and Salmonella enterica, compared to the C-films. High-pressure homogenization significantly reduced the emulsion’s particle size, from 11.59 to 2.55 μm, and considerably enhanced the M-film’s uniformity, hydrophobicity, and structural quality. Most importantly, the M-films exhibited lower oxygen transmission (35.14 cc/m2/day) and water vapor transmission rates (52.12 g/m2/day) than the C-films at 45.1 and 65.5 cc/m2/day, respectively, indicating superior protection against gas and moisture diffusion. Markedly improved mechanical properties, including foldability, toughness, and bubble-free surfaces, were also observed, making the M-films suitable for practical applications. This study highlights the potential of high-pressure homogenization as a method for enhancing the functional properties of hemicellulose-based films (i.e., M-films). The fabricated films offer a viable alternative to conventional plastic packaging, paving the way for safer and greener solutions tailored to modern industry needs.
No takes yet. Share an insight, caveat, or question.
Hussain et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: